Institutional Manager · CIK 0001697013
Eversept Partners, LP
NEW YORK, NY · File #028-18369
Latest AUM
$1.98B
Positions
107
Top-10 Concentration
53.7%
Filings
20
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| ADD | UNITED THERAPEUTICS CORP DEL | UTHR | +236,392 | +$115.2M | +$1.1M |
| REDUCE | NATERA INC | NTRA | -185,151 | -$42.4M | +$35.4M |
| EXITED | ZIMVIE INC | 98888T107 | -2,079,380 | -$39.4M | $0 |
| ADD | ABIVAX SA | AAVXF | +231,335 | +$31.2M | +$21.3M |
| NEW | SPDR S&P 500 ETF TR | SPY | +44,900 | +$30.6M | $0 |
| ADD | GSK PLC | GLAXF | +559,275 | +$27.4M | +$12.5M |
| ADD | AVANTOR INC | AVTR | +2,252,202 | +$25.8M | -$942,931 |
| NEW | EXACT SCIENCES CORP | 30063P105 | +241,678 | +$24.5M | $0 |
| REDUCE | REVVITY INC | RVTY | -231,534 | -$22.4M | +$3.6M |
| REDUCE | TEVA PHARMACEUTICAL INDS LTD | 881624209 | -703,476 | -$22.0M | +$15.0M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 2025107 pos · $1.98B
- 13F HOLDINGS REPORTQ/E Sep 202586 pos · $1.45B
- 13F HOLDINGS REPORTQ/E Jun 202568 pos · $1.09B
- 13F HOLDINGS REPORTQ/E Mar 202557 pos · $984.7M
- 13F HOLDINGS REPORTQ/E Dec 202465 pos · $1.13B
- 13F HOLDINGS REPORTQ/E Sep 202467 pos · $1.46B
- 13F HOLDINGS REPORTQ/E Jun 202474 pos · $1.46B
- 13F HOLDINGS REPORTQ/E Mar 202470 pos · $1.50B
- 13F HOLDINGS REPORTQ/E Dec 202369 pos · $1.18B
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202383 pos · $1.33B
- 13F HOLDINGS REPORT (Amended)Q/E Dec 20231 pos · $698,608
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202369 pos · $1.15B
- 13F HOLDINGS REPORT (Amended)Q/E Dec 20231 pos · $672,735
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202376 pos · $1.41B
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202357 pos · $322.4M
- 13F HOLDINGS REPORT (Amended)Q/E Dec 20232 pos · $579,795
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202387 pos · $1.50B
- 13F HOLDINGS REPORT (Amended)Q/E Dec 20231 pos · $636,437
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202361 pos · $402.3M
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202371 pos · $1.20B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | VERA THERAPEUTICS INC | VERA | 3,072,304 | $155.6M | 8.90% |
| 2 | INVESCO QQQ TR | IVZ | 225,000 | $138.2M | 7.91% |
| 3 | GSK PLC | GLAXF | 2,679,721 | $131.4M | 7.52% |
| 4 | UNITED THERAPEUTICS CORP DEL | UTHR | 252,592 | $123.1M | 7.04% |
| 5 | ABIVAX SA | AAVXF | 657,834 | $88.7M | 5.07% |
| 6 | NATERA INC | NTRA | 334,493 | $76.6M | 4.38% |
| 7 | SYNDAX PHARMACEUTICALS INC | SNDX | 3,314,408 | $69.6M | 3.98% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,782,235 | $55.5M | 3.17% |
| 9 | VAXCYTE INC | PCVX | 1,197,722 | $55.3M | 3.16% |
| 10 | TRAVERE THERAPEUTICS INC | TVTX | 1,174,968 | $44.9M | 2.57% |
| 11 | HCA HEALTHCARE INC | HCA | 95,874 | $44.8M | 2.56% |
| 12 | DANAHER CORPORATION | 235851102 | 186,262 | $42.6M | 2.44% |
| 13 | IONIS PHARMACEUTICALS INC | IONS | 538,218 | $42.6M | 2.44% |
| 14 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,434,725 | $39.0M | 2.23% |
| 15 | BRUKER CORP | BRKRP | 783,789 | $36.9M | 2.11% |
| 16 | AVANTOR INC | AVTR | 3,176,644 | $36.4M | 2.08% |
| 17 | SPDR S&P 500 ETF TR | SPY | 44,900 | $30.6M | 1.75% |
| 18 | COMMUNITY HEALTH SYS INC NEW | 203668108 | 7,943,802 | $24.8M | 1.42% |
| 19 | EXACT SCIENCES CORP | 30063P105 | 241,678 | $24.5M | 1.40% |
| 20 | BIOCRYST PHARMACEUTICALS INC | BCRX | 2,992,895 | $23.3M | 1.34% |